Anda Vlad

2.7k total citations
53 papers, 2.0k citations indexed

About

Anda Vlad is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Anda Vlad has authored 53 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Immunology, 19 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Anda Vlad's work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (13 papers) and Ovarian cancer diagnosis and treatment (13 papers). Anda Vlad is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (13 papers) and Ovarian cancer diagnosis and treatment (13 papers). Anda Vlad collaborates with scholars based in United States, Romania and United Kingdom. Anda Vlad's co-authors include Olivera J. Finn, Robert P. Edwards, Esther Elishaev, Raluca A. Budiu, Casey A. Carlos, Nehad M. Alajez, Lixin Zhang, Simon C. Watkins, George C. Tseng and Gina Mantia-Smaldone and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Anda Vlad

50 papers receiving 2.0k citations

Peers

Countries citing papers authored by Anda Vlad

Since Specialization

Citations

This map shows the geographic impact of Anda Vlad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anda Vlad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anda Vlad more than expected).

Fields of papers citing papers by Anda Vlad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anda Vlad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anda Vlad. The network helps show where Anda Vlad may publish in the future.

Co-authorship network of co-authors of Anda Vlad

This figure shows the co-authorship network connecting the top 25 collaborators of Anda Vlad. A scholar is included among the top collaborators of Anda Vlad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anda Vlad. Anda Vlad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites 2024 ·Frontiers in Immunology ·Lixin Zhang, (unknown), Esther Elishaev, Syed Ziauddin A. Zaidi, Francesmary Modugno, (unknown), Robert P. Edwards, Olivera J. Finn, Anda Vlad	1
2	Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer 2024 ·Cancers ·(unknown), Michael W. Epperly, Renee Fisher, Wen‐Chi Hou, Donna Shields, Jan‐Peter van Pijkeren, Brian J. Leibowitz, Lan Coffman, Hong Wang, M. Saiful Huq, Ziyu Huang, Claude J. Rogers, Anda Vlad, Joel S. Greenberger, Amitava Mukherjee	4
3	Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce Chemotherapy Resistance in Surrounding Cells in Response to Chemotherapy 2023 ·Clinical Cancer Research ·Alexander J. Cole, (unknown), Jaynish S. Shah, (unknown), (unknown), (unknown), (unknown), Anda Vlad, Francesmary Modugno, Robert P. Edwards, Ronald J. Buckanovich	6
4	Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri-IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation 2023 ·Cancers ·(unknown), Michael W. Epperly, Renee Fisher, Wen‐Chi Hou, Donna Shields, Jan‐Peter van Pijkeren, Amitava Mukherjee, Jian Yu, Brian J. Leibowitz, Anda Vlad, Lan Coffman, Hong Wang, M. Saiful Huq, Ziyu Huang, Claude J. Rogers, Joel S. Greenberger	7
5	Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression 2023 ·OncoImmunology ·Paul G. Pavicic, Patricia Rayman, Shadi Swaidani, (unknown), Vladimir Makarov, Charles S. Tannenbaum, Robert P. Edwards, Anda Vlad, C. Marcela Díaz‐Montero, Haider Mahdi	9
6	Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation 2022 ·Cancer Research ·Huda I. Atiya, Leonard Frisbie, (unknown), (unknown), Nicole Donnellan, Francesmary Modugno, Michael Calderon, Simon C. Watkins, Rugang Zhang, Esther Elishaev, T. Rinda Soong, Anda Vlad, Lan Coffman	30
7	Cancer-associated MSC drive tumor immune exclusion and resistance to immunotherapy, which can be overcome by Hedgehog inhibition 2021 ·Science Advances ·Sandra Cascio, Chelsea Chandler, (unknown), (unknown), Bingsi Gao, Sayali Onkar, Tullia C. Bruno, Dario A.A. Vignali, Haider Mahdi, Hatice U. Osmanbeyoglu, Anda Vlad, Lan Coffman, Ronald J. Buckanovich	54
8	The Evolution of Estrogen Receptor Signaling in the Progression of Endometriosis to Endometriosis-Associated Ovarian Cancer 2018 ·Hormones and Cancer ·Courtney L. Andersen, M.M. Boisen, Matthew J. Sikora, Tianzhou Ma, George C. Tseng, (unknown), Anda Vlad, Esther Elishaev, Robert P. Edwards, Steffi Oesterreich	11
9	Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade 2018 ·Oncogene ·Qin Ye, Shauna N. Vasilatos, Lin Chen, Hao Wu, (unknown), Yumei Fu, Min Huang, Anda Vlad, Binfeng Lu, Steffi Oesterreich, Nancy E. Davidson, Yi Huang	166
10	Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles 2018 ·Oncogene ·Shannon Grabosch, Mirna Bulatović, (unknown), Tianzhou Ma, Lixin Zhang, Malcolm S. Ross, (unknown), Yusi Fang, George C. Tseng, Eun Sun Kim, Andrea Gambotto, Esther Elishaev, Robert P. Edwards, Anda Vlad	214
11	Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study 2017 ·Gynecologic Oncology ·Shannon Grabosch, George C. Tseng, Robert P. Edwards, Heather A. Lankes, Kathleen N. Moore, Kunle Odunsi, Anda Vlad, Tianzhou Ma, (unknown), (unknown), Amit A. Lugade, Angela R. Omilian, Wiam Bshara, Ashley Stuckey, Joan L. Walker, Michael J. Birrer	4
12	Effects of Kras activation and Pten deletion alone or in combination on MUC1 biology and epithelial-to-mesenchymal transition in ovarian cancer 2016 ·Oncogene ·Lin Zhang, Tonghui Ma, (unknown), (unknown), Raluca A. Budiu, George C. Tseng, Anda Vlad	22
13	Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model 2016 ·PubMed ·Raluca A. Budiu, Anda Vlad, (unknown), (unknown), Kristine Cooper, (unknown), Premal H. Thaker, Julie Urban, Paweł Kaliński, Adrian V. Lee, Esther Elishaev, Thomas P. Conrads, Melanie S. Flint	27
14	Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model 2015 ·Cancer Immunology Immunotherapy ·(unknown), Lixin Zhang, Tianzhou Ma, Shannon Grabosch, (unknown), (unknown), George C. Tseng, Esther Elishaev, Robert P. Edwards, Xin Huang, Anda Vlad	19
15	Robust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples 2015 ·Scientific Reports ·Stefan Graw, Richard Meier, Kay Minn, Clark Bloomer, Andrew K. Godwin, Brooke L. Fridley, Anda Vlad, Peter Beyerlein, Jeremy Chien	53
16	Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer 2014 ·Clinical Cancer Research ·(unknown), Xin Huang, Esther Elishaev, Raluca A. Budiu, Lixin Zhang, Sung‐Hwan Kim, Nicole Donnellan, Gina Mantia-Smaldone, Tianzhou Ma, George C. Tseng, Ted Lee, Suketu Mansuria, Robert P. Edwards, Anda Vlad	102
17	Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer 2013 ·Clinical Cancer Research ·(unknown), Anda Vlad, (unknown), Gina Mantia-Smaldone, Robin Laskey, MinJae Lee, Yan Lin, Nicole Donnellan, (unknown), Ted Lee, Suketu Mansuria, Esther Elishaev, Raluca A. Budiu, Robert P. Edwards, Xin Huang	158
18	Immunobiology of human mucin 1 in a preclinical ovarian tumor model 2012 ·Oncogene ·Raluca A. Budiu, Esther Elishaev, (unknown), (unknown), Robert P. Edwards, Paweł Kaliński, Anda Vlad	27
19	Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies 2010 ·Cancer Management and Research ·(unknown), (unknown), Anda Vlad	51
20	MUC1 Immunobiology: From Discovery to Clinical Applications 2004 ·Advances in immunology ·Anda Vlad, (unknown), Nehad M. Alajez, Casey A. Carlos, Olivera J. Finn	174

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact